Heron Therapeutics In A Tough Spot After Cinvanti Court Loss (Rating Downgrade)
Heron Therapeutics Inc HRTX
$0.42
▲ +7.80%
(+$0.03)
Open
$0.40
Prev Close
$0.39
Day Range
$0.39 – $0.42
52W Range
$0.38 – $2.30
Market Cap
$79.02M
Beta
1.69
EPS (TTM)
$-0.18
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1987-08-26 |
| Shares Out. | 189,280,000 |
| Website | herontx.com/ ↗ |
| Phone | 13026365400 |
Heron Therapeutics Inc is a publicly traded company under the ticker symbol HRTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-06-01)